Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Tubulointerstitial Nephritis after Using a Sodium-glucose Cotransporter 2 Inhibitor
Yusuke KontaEiichiro SaitoKoji SatoKyohei FurutaKenichiro MiyauchiAkiko FurukawaHiroshi SatoTae Yamamoto
著者情報
ジャーナル オープンアクセス

2022 年 61 巻 21 号 p. 3239-3243

詳細
抄録

We herein report a case of acute kidney injury (AKI) due to tubulointerstitial nephritis (TIN) after starting empagliflozin in a diabetic patient. The patient developed stage 1 AKI with proteinuria and elevated tubulointerstitial markers. A renal biopsy showed acute TIN with lymphocytic infiltration into the interstitium. The patient's renal function improved after discontinuation of empagliflozin and steroid administration. Sodium-glucose cotransporter 2 (SGLT2) inhibitor-induced AKI has been reported, but the underlying mechanism remains unclear, potentially because few patients with SGLT2-inhibitor-induced AKI have undergone a renal biopsy. We report the present case in the hope that it will help clarify the mechanism.

著者関連情報
© 2022 by The Japanese Society of Internal Medicine
前の記事 次の記事
feedback
Top